{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:39:53Z","timestamp":1782520793697,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Jesse Brown VA Medical Center","award":["BX003692"],"award-info":[{"award-number":["BX003692"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.urolonc.2018.09.017","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T09:48:38Z","timestamp":1542102518000},"page":"818-825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patients"],"prefix":"10.1016","volume":"37","author":[{"given":"Damiano","family":"Fantini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3529-2088","authenticated-orcid":false,"given":"Roland","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Meeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2018.09.017_bib0001","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0002","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2011.03.023","article-title":"Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines","volume":"59","author":"Stenzl","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0003","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0004","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.eururo.2005.12.011","article-title":"Prevention of bladder cancer: a review","volume":"49","author":"Leppert","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0005","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0006","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194039","article-title":"Smoking intensity and bladder cancer aggressiveness at diagnosis","volume":"13","author":"Barbosa","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0008","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.dnarep.2016.05.027","article-title":"Mutational signature of aristolochic acid: clue to the recognition of a global disease","volume":"44","author":"Rosenquist","year":"2016","journal-title":"DNA Repair"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0009","doi-asserted-by":"crossref","first-page":"197ra102","DOI":"10.1126\/scitranslmed.3006200","article-title":"Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing","volume":"5","author":"Hoang","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0011","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng.3503","article-title":"Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer","volume":"48","author":"Al-Ahmadie","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0012","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.eururo.2014.06.050","article-title":"Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder","volume":"67","author":"Kim","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0013","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ng.3557","article-title":"Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors","volume":"48","author":"Kim","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0014","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0015","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41388-017-0099-6","article-title":"A carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer","volume":"37","author":"Fantini","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0016","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/2159-8290.CD-14-0623","article-title":"Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma","volume":"4","author":"Van Allen","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0017","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0018","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrurol.2017.11","article-title":"The evolving genomic landscape of urothelial carcinoma","volume":"14","author":"Glaser","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0019","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.18632\/oncotarget.23344","article-title":"APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response","volume":"9","author":"Glaser","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0020","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00432-018-2639-z","article-title":"No influence of smoking status on the performance of urine markers for the detection of bladder cancer","volume":"144","author":"Deininger","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0021","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.eururo.2017.03.030","article-title":"Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy","volume":"72","author":"Seiler","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0022","doi-asserted-by":"crossref","first-page":"l1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0023","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/ng.2798","article-title":"Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation","volume":"45","author":"Guo","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0024","doi-asserted-by":"crossref","first-page":"eaal0180","DOI":"10.1126\/scisignal.aal0180","article-title":"A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia","volume":"10","author":"Suply","year":"2017","journal-title":"Sci Signal"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12890-017-0509-0","article-title":"Tobacco-smoking induced GPR15-expressing T cells in blood do not indicate pulmonary damage","volume":"17","author":"Bauer","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0026","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1177\/1535370217703977","article-title":"Activation of GPR15 and its involvement in the biological effects of smoking","volume":"242","author":"Koks","year":"2017","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0027","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1091\/mbc.e16-08-0573","article-title":"Chromatin association of XRCC5\/6 in the absence of DNA damage depends on the XPE gene product DDB2","volume":"28","author":"Fantini","year":"2017","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0028","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1158\/0008-5472.CAN-17-1570","article-title":"DDB2 is a novel regulator of Wnt signaling in colon cancer","volume":"77","author":"Huang","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0029","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mrrev.2013.02.003","article-title":"Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid","volume":"753","author":"Hollstein","year":"2013","journal-title":"Mutat Res"},{"key":"10.1016\/j.urolonc.2018.09.017_bib0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.euf.2015.12.002","article-title":"Accuracy of self-reported smoking exposure among bladder cancer patients undergoing surveillance at a tertiary referral center","volume":"2","author":"Thong","year":"2016","journal-title":"Eur Urol Focus"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143918303818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143918303818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:17:00Z","timestamp":1761041820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143918303818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1078143918303818"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.09.017","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patients","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}